Results 41 to 50 of about 162,548 (258)

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Predicting Composition Dependence of Glass Forming Ability in Ternary Al-Cu-Y System by Thermodynamic Calculation

open access: yesMetals, 2014
The composition dependence of glass forming ability in the ternary Al-Cu-Y system is predicted by thermodynamic calculations based on the Miedema’s model and Alonso’s method.
Qi Wang   +3 more
doaj   +1 more source

Glass-forming ability and thermal stability of F-phlogopite-based glasses [PDF]

open access: yesJournal of Thermal Analysis and Calorimetry, 2015
Peer ...
Casasola, Raquel   +2 more
openaire   +2 more sources

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

MITF maintains genome stability in nonmelanocyte lineages

open access: yesMolecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir   +13 more
wiley   +1 more source

Micro-lateral extrusion of Zr55Cu30Al10Ni5 bulk metallic glass under low-frequency vibration loading

open access: yesMATEC Web of Conferences, 2015
The effect of vibration on the micro-forming ability of Zr55Cu30Al10Ni5 bulk metallic glass in its supercooled liquid region was studied. The experiment of micro-extrusion was carried out under different amplitude (38 ∼ 760 N) and different frequency (0 ...
Li Jinyang   +3 more
doaj   +1 more source

A New Ni-Based Metallic Glass with High Thermal Stability and Hardness

open access: yesMetals, 2015
Glass forming ability (GFA), thermal stability and microhardness of Ni51−xCuxW31.6B17.4 (x = 0, 5) metallic glasses have been investigated. For each alloy, thin sheets of samples having thickness of 20 µm and 100 µm were synthesized by piston and anvil
Aytekin Hitit   +3 more
doaj   +1 more source

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

open access: yesMolecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur   +11 more
wiley   +1 more source

Radial dependence of thermal, structural and micro deformation characteristics in Cu-Zr-Al bulk metallic glass subjected to high pressure torsion

open access: yesMaterials & Design
Disk of a Cu38Zr54Al8 bulk metallic glass was subjected to severe plastic deformation by high pressure torsion up to 25 revolutions. X-ray diffraction was utilized to investigate the microstructure of the deformed sample, while the thermal behavior of ...
Talaye Arjmandabasi   +5 more
doaj   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

open access: yesMolecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy